Tracking new lupus Treatment's Real-Life impact
NCT ID NCT07424261
Summary
This study follows 125 adults with lupus who are starting treatment with anifrolumab injections. Researchers will track patients for 2 years to see how well the medication controls lupus symptoms and improves quality of life in real-world medical settings. The study focuses on whether patients achieve remission or low disease activity while using this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.